The Latest Breaking News from Tetra

There are three ways to shut down an annoying conversation – but are they too brutal?

We’ve all had meetings that could have been emails. Often, this also applies to casual chats with your friends, writes Polly Hudson

The Guardian - UK · Sep 6

Forget Brompton, this folding bike mixes convenience with out-of-this-world, sci-fi design

The Tetra folding bike looks like it rolled straight out of a sci-fi movie

T3 · Jul 11

Arbouring offenders: Italian town’s tree-climbing ban prompts outcry

Critics say plan to issue fines of up to €500 for climbing trees in Oderzo’s public spaces is ‘absurd’

The Guardian - UK · Apr 18, 2024

Tetra Partners With Cellvera To Develop An Oral Treatment For COVID-19

Tetra Bio-Pharma Inc.

Benzinga · Sep 6, 2022

Signs of mental exhaustion you shouldn't ignore - headaches to feeling trapped

Mental exhaustion and stress are slightly different in that stress can often come and go, but lingering mental fatigue can affect a person’s ability to think, solve problems, or process and regulate emotions

Daily Mirror · Aug 17, 2022

Preclinical Trial Results Confirm Targeting Type 2 Cannabinoid Receptors Helps Relieve Sepsis-Related Condition

Tetra Bio-Pharma Inc. (OTCQB: TBPMF) (TSX:TBP) (FRA:JAM1) revealed positive preclinical results from live SARS-CoV-2 virus infection studies as well as a septic lung model, carried out by independent researchers.

Benzinga · Aug 10, 2022

Akanda To Supply Tetra Bio-Pharma With Cannabis For FDA Trials Of Cancer-Pain Drug

Akanda Corp.

Benzinga · Jul 12, 2022

Ayurcann To Acquire Joints And Hustle & Shake Cannabis Brands For 5.5M In Stock

Ayurcann Holdings Corp. (OTCQB: AYURF) (CSE:AYUR) (FSE: 3ZQ0) entered into a share purchase agreement, pursuant to which the company will acquire 100% of Joints and Hustle & Shake Inc. for $5.5 million.

Benzinga · Jun 22, 2022

Tetra Bio-Pharma Opens New Subsidiary In Australia And Provides Regulatory Update

Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB: TBPMF) (FRA:JAM1) launched new wholly owned subsidiary 'Tetra Bio-Pharma Australia Pty Ltd', an Australian-based research company focused on the execution of clinical trials in Australia.

Benzinga · Jun 6, 2022

Tetra Bio-Pharma Receives EMA Orphan Drug Designation For A Novel Topical Therapeutic Containing CBD

The European Medicines Agency (EMA) has classified Tetra Bio-Pharma Inc.’s (OTCQB: TBPMF) (TSX:TBP) (FRA:JAM1) PPP004 as an orphan medicinal product for the treatment for epidermolysis bullosa (EB).

Benzinga · May 18, 2022